Sensitivity and specificity of S2BI for identifying alcohol and cannabis use disorders among adolescents presenting for primary care

References

• National Institute on Alcohol Abuse and Alcoholism (US). Alcohol Screening and Brief Intervention for Youth: A Practitioner’s Guide. National Institute on Alcohol Abuse and Alcoholism, US Department of Health and Human Services, National Institutes of Health; 2011. https://pubs.niaaa.nih.gov/publications/Practitioner/YouthGuide/YouthGuide.pdf. Accessed July 20, 2018.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Systems-Level Implementation of Screening, Brief Intervention, and Referral to Treatment. Technical Assistance Publication (TAP) Series 33. HHS Publication No. (SMA) 13-4741. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013. http://www.integration.samhsa.gov/sbirt/tap33.pdf. Accessed April 7, 2015.
   Google Scholar
• Levy S, Shrier LA. Adolescent SBIRT Toolkit for Providers. https://massclearinghouse.ehs.state.ma.us/PROG-BSAS-SBIRT/SA1099.html. Published 2015.
   Google Scholar
• AAP Committee on Substance Use and Prevention. Screening, brief intervention, and referral to treatment. Pediatrics. 2016;138(1):e20161211.
   PubMedGoogle Scholar
• Wisk LE, Weitzman ER. Substance use patterns through early adulthood: results for youth with and without chronic conditions. Am J Prev Med. 2016;51(1):33–45.
   PubMed Web of Science ®Google Scholar
• Committee on Substance Abuse. Substance use screening, brief intervention, and referral to treatment for pediatricians. Pediatrics. 2011;128(5):e1330–e1340.
   PubMed Web of Science ®Google Scholar
• McCarty CA, Levy S, Harris SK. Alcohol use screening and behavioral counseling with adolescents in primary care: a call to action. JAMA Pediatr. 2019;173(1):12–14.
   PubMed Web of Science ®Google Scholar
• Rehm J, Baliunas D, Borges GLG, et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 2010;105(5):817–843.
   PubMed Web of Science ®Google Scholar
• Weitzman ER, Ziemnik RE, Huang Q, Levy S. Alcohol and marijuana use and treatment nonadherence among medically vulnerable youth. Pediatrics. 2015;136(3):450–457.
   PubMed Web of Science ®Google Scholar
• Harstad E, Levy S. Committe on Substance Abuse. Attention-deficit/hyperactivity disorder and substance abuse. Pediatrics. 2014;134(1):e293-301–e301.
   PubMed Web of Science ®Google Scholar
• Shrier LA, Harris SK, Kurland M, Knight JR. Substance use problems and associated psychiatric symptoms among adolescents in primary care. Pediatrics. 2003;111(6 Pt 1):e699–e705.
   PubMed Web of Science ®Google Scholar
• Elkind AH. Drug abuse and headache. Med Clin North Am. 1991;75(3):717–732.
   PubMed Web of Science ®Google Scholar
• Dimitrijević I, Kalezić N, Ristić J, Bojović O, Dimitrijević N. Digestive system damage caused by substance abuse. Acta Chir Iugosl. 2008;55(3):133–138.
   PubMedGoogle Scholar
• Weitzman ER, Magane KM, Wisk LE, Allario J, Harstad E, Levy S. Alcohol use and alcohol-interactive medications among medically vulnerable youth. Pediatrics. 2018;142(4):e20174026.
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task Force. Draft recommendation statement: illicit drug use, including nonmedical use of prescription drugs: screening. https://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement/drug-use-in-adolescents-and-adults-including-pregnant-women-screening. Published 2019. Accessed September 17, 2019.
   Google Scholar
• National Institute on Drug Abuse. Principles of adolescent substance use disorder treatment: a research-based guide. https://www.drugabuse.gov/publications/principles-adolescent-substance-use-disorder-treatment-research-based-guide/principles-adolescent-substance-use-disorder-treatment. Published 2014. Accessed January 29, 2014.
   Google Scholar
• Knight JR, Shrier LA, Bravender TD, Farrell M, Vander Bilt J, Shaffer HJ. A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med. 1999;153(6):591–596.
   PubMed Web of Science ®Google Scholar
• Dhalla S, Zumbo BD, Poole G, Poolem G. A review of the psychometric properties of the CRAFFT instrument: 1999–2010. Curr Drug Abuse Rev. 2011;4(1):57–64.
   PubMedGoogle Scholar
• Spirito A, Bromberg JR, Casper TC, et al. Reliability and validity of a two-question alcohol screen in the pediatric emergency department. Pediatrics. 2016;138(6):e20160691–e20160691.
   PubMed Web of Science ®Google Scholar
• DAmico EJ, Parast L, Meredith LS, Ewing BA, Shadel WG, Stein BD. Screening in primary care: what is the best way to identify at-risk youth for substance use? Pediatrics. 2016;138(6):e20161717–e20161717.
   PubMed Web of Science ®Google Scholar
• Levy S, Dedeoglu F, Gaffin JM, et al. A screening tool for assessing alcohol use risk among medically vulnerable youth. Vrana KE, ed. PLoS One. 2016;11(5):e0156240.
   PubMed Web of Science ®Google Scholar
• Levy S, Weiss R, Sherritt L, et al. An electronic screen for triaging adolescent substance use by risk levels. JAMA Pediatr. 2014;168(9):822–828.
   PubMed Web of Science ®Google Scholar
• Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O'Grady KE, Schwartz RP. Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use. Pediatrics. 2014;133(5):819–826.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
   Google Scholar
• Pitts S, Shrier LA. Substance abuse screening and brief intervention for adolescents in primary care. Pediatr Ann. 2014;43(10):e248–e252.
   Web of Science ®Google Scholar
• Adolescent Substance Use Screening Tools. National Institute on Drug Abuse (NIDA). https://www.drugabuse.gov/adolescent-substance-use-screening-tools. Accessed September 10, 2019.
   Google Scholar
• Cottler LB. Composite International Diagnostic Interview–Substance Abuse Module (CIDI-SAM). St. Louis, MO: Department of Psychiatry, Washington University School of Medicine; 2000.
   Google Scholar
• Arroll B, Goodyear-Smith F, Crengle S, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. 2010;8(4):348–353.
   PubMed Web of Science ®Google Scholar
• Skapinakis P. The 2-item generalized anxiety disorder scale had high sensitivity and specificity for detecting GAD in primary care. Evid Based Med. 2007;12(5):149.
   PubMedGoogle Scholar
• Gryczynski J, Mitchell SG, Schwartz RP, et al. Disclosure of adolescent substance use in primary care: comparison of routine clinical screening and anonymous research interviews. J Adolesc Heal. 2019;64(4):541–543.
   PubMed Web of Science ®Google Scholar
• DiFranza JR, Richmond JB. Let the children be heard: lessons from studies of the early onset of tobacco addiction. Pediatrics. 2008;121(3):623–624.
   PubMed Web of Science ®Google Scholar
• Sterling S, Kline-Simon AH, Wibbelsman C, Wong A, Weisner C. Screening for adolescent alcohol and drug use in pediatric health-care settings: predictors and implications for practice and policy. Addict Sci Clin Pract. 2012;7(1):13.
   PubMedGoogle Scholar
• Levy S, Ziemnik RE, Harris SK, et al. Screening adolescents for alcohol use: tracking practice trends of Massachusetts pediatricians. J Addict Med. 2017;11(6):427–434.
   PubMed Web of Science ®Google Scholar
• Barry KL, Blow FC, Willenbring ML, McCormick R, Brockmann LM, Visnic S. Use of alcohol screening and brief interventions in primary care settings: implementation and barriers. Subst Abus. 2004;25(1):27–36.
   PubMedGoogle Scholar
• Levy S, Wiseblatt A, Straus J, Strother H, Fluet C, Harris S. Adolescent SBIRT practices among pediatricians in Massachusetts. J Addict Med. 2019;14(2):145–149.
   Web of Science ®Google Scholar
• Wilson CR, Sherritt L, Gates E, Knight JR. Are clinical impressions of adolescent substance use accurate?. Pediatrics. 2004;114(5):e536–e540.
   PubMed Web of Science ®Google Scholar
• Robins LN, Wing J, Wittchen HU, et al. The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45(12):1069–1077.
   PubMed Web of Science ®Google Scholar
• Cottler LB, Robins LN, Helzer JE. The reliability of the CIDI-SAM: a comprehensive substance abuse interview. Br J Addict. 1989;84(7):801–814.
   PubMedGoogle Scholar